|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Indinavir concentrations and St John' s wort 显示文摘 | Piscitelli SC Burstein AH Chaitt D | 2000 | Lancet2000，355，： | 1 |
| 2 | Clinical pharmacology of systemic antifungal agents:a comprehensive review of agents in clinical use,current investigational compounds,and putative targets for antifungal drug development显示文摘 | Groll AH Piscitelli SC Walsh TJ | 1998 | Adv Pharmacol1998，44，7： | 1 |
| 3 | Clinical pharmacology of systemic antifungal agents:A comprehensive review of agents in clinical use,current investigational compounds,and putative targets for antifungal drug development显示文摘 | Groll AH Piscitelli SC Walsh TJ | 1998 | Adv Pharmacol1998，44，： | 1 |
| 4 | Clarithromycin and azithromycin: new macrolide antibiotics 显示文摘 | Piscitelli SC Danziger LH Rodvold KA | 1992 | Clinical Phar- macy1992，11，2： | 1 |
| 5 | Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development 显示文摘 | Groll AH Piscitelli SC Walsh TJ | 1998 | Adv Pharmacol1998，44，1： | 1 |
| 6 | Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers显示文摘 | Piscitelli SC Formentini E Burstein AH | 2002 | Pharmacotherapy2002，22，： | 1 |
| 7 | Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers显示文摘 | Piscitelli SC Formentini E Burstein AH | 2002 | Pharm acotherapy2002，22，5： | 1 |
| 8 | A multiple drug interaction study of stavudine with agents for opportunistic infections in human immunodefieciency virus-infected patients显示文摘 | Piscitelli SC KelIy G Walker RE | 1999 | Antimicrob Agents Chemother1999，43，： | 1 |
| 9 | Update on prevention vertical transmission of HIV type 1显示文摘 | Pau AR Piscitelli SC | 2000 | Am J Health Syst Pharm2000，57，： | 1 |
| 10 | Single- dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients显示文摘 | Piscitelli SC Figg WD Hahn B | 1997 | Antimicrob Agents Chemother1997，41，12： | 1 |
| 11 | Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine显示文摘 | PISCITELLI SC THIBAULT A FIGG WD | 1995 | J Clin Pharmacol1995，35，4： | 1 |
| 12 | Penetration of tacrineinto cerebrospinal fluid in patients with Alzheimer's disease显示文摘 | Grothe DH Piscitelli SC Dukoff R | 1998 | JClin Psychopharmacol1998，18，1： | 1 |
| 13 | Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylglutamine 显示文摘 | Piscitelli SC Thibault A Figg WD | 1995 | J Clin Pharmacol1995，35，2： | 1 |
| 14 | The effect of garlic supplements on the pharmacokinetics of saquinavir显示文摘 | Piscitelli SC Burstein All Welden N | 2002 | Chn Infect Dis2002，34，： | 1 |
| 15 | Interactions among drugs for HIV and opportunistic infections显示文摘 | Piscitelli SC Gallicano KD | 2001 | N Engl J Med2001，344，13： | 1 |
| 16 | Candidal ufinay tract infections : a comprehensive review of their diagnosis and manage- ment 显示文摘 | Gubbins PO Piscitelli SC Danziger LH | 1993 | Pharmacotherapy1993，13，2： | 1 |
| 17 | A risk-benefit assessment of inter- leukin-2 as an adjunct to antiviral therapy in HIV infection显示文摘 | Piscitelli SC N Bhat A Pau | 2000 | DrugSaf2000，22，1： | 1 |
| 18 | Clarithromycin and azithromin:new macrolide antibiotics显示文摘 | Piscitelli SC Danziger LH Rodvold KA | 1992 | Clin Pharmacy1992，11，： | 1 |
| 19 | Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development显示文摘 | Groll AH Piscitelli SC Walsh TJ | 1998 | Adv Pharmacol1998，44，： | 1 |
| 20 | Clinical pharmacology of systemic antifungal agnets : a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development 显示文摘 | Groll AH Piscitelli SC Walsh TJ | 1998 | Adv Pharmacol1998，44，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员